Latest News

Computing cancer amidst a deluge of data

Imagine if you could read all 3 million letters that make up the human genetic code. “Why would you want to?” you might ask. Well, by finding the differences between the sequences of a cancer and ....

Conference Spotlight

Precision Medicine World Conference (PMWC) 2017

PMWC 2017 Silicon Valley on January 23-25, co-hosted by Stanford Health Care, UCSF, Intermountain Healthcare, Duke Health, and Duke University, covers all facets of Precision Medicine including current hot topics like immunotherapy, the Precision Medicine Initiative, liquid biopsy, the human microbiome, big data, and cancer & companion diagnostics.


Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity.

Recently, there has been a coordinated effort from academic institutions and the pharmaceutical industry to identify biomarkers that can predict responses to immune checkpoint blockade in cancer. Seve ....

Decision Algorithms

Direct-to-Consumer Genetic Testing: User Motivations, Decision Making, and Perceived Utility of Results.

To describe the interests, decision making, and responses of consumers of direct-to-consumer personal genomic testing (DTC-PGT) services. Prior to 2013 regulatory restrictions on DTC-PGT services, 1, ....

Product News

bioMrieux and Banyan to develop biomarkers for Traumatic Brain Injury

PARIS. bioMérieux, a world leader in the field of in vitro diagnostics, and Banyan Biomarkers, an innovative biomarkers company developing blood tests capable of diagnosing traumatic brain injuries ( ....


Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

This paper presents a review of the importance and role of precision medicine and molecular imaging technologies in cancer diagnosis with therapeutics and diagnostics purposes. Precision medicine is p ....


Genomic hallmarks of localized, non-indolent prostate cancer.

Prostate tumours are highly variable in their response to therapies, but clinically available prognostic factors can explain only a fraction of this heterogeneity. Here we analysed 200 whole-genome se ....

Pipeline News

Daiichi Sankyo Initiates Phase 1/2 Study of Novel Antibody Drug Conjugate U3-1402 in Patients with HER3-Positive Metastatic or Unresectable Breast Cancer

TOKYO. Daiichi Sankyo Company, Limited announced today the initiation of a three-part open-label phase 1/2 study in Japan with U3-1402, a novel HER3-targeting antibody drug conjugate, in patients with ....

Issued Patents

Blood Markers For Diagnosing Epithelium Derived Cancers And Monoclonal Antibodies Thereof

The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodi ....

Patent Applications

Dna-decorated Graphene Chemical Sensors

The present invention provides a broad response single-stranded DNA-graphene chemical sensor device. The present invention also provides methods for improving the ability of graphene to work as a chem ....


Toward Automating HIV Identification: Machine Learning for Rapid Identification of HIV-Related Social Media Data.

“Social big data” from technologies such as social media, wearable devices, and online searches continue to grow and can be used as tools for HIV research. Although researchers can uncover ....

Funding News
Sensors and Wearables

Biosensor is able to detect cancer antibodies at early stages

MADRID. Before a malignant tumor is developed, the immune system tries to fight against proteins that are altered during their formation, producing certain cancer antibodies. A biosensor developed by ....

Recruiting Trials

Inflammatory Response in Myocardial Infarction Evaluated by MRI and Biomarkers

An intense inflammatory reaction is triggered by the ischemic injury during myocardial infarction. The inflammatory processes involved are complex and haven’t been explored in detail in hu ....

Awarded Grants